Scientist – Preclinical Team
Full-timeMIDCapricor TherapeuticsRare Diseases
$95K - $115K/yr(from employer)
Description
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
We are seeking a Science to join our Pre-Clinical team to support the progression of our therapeutic programs through the design, execution, and optimization of in vivo research activities and preclinical studies. This role requires deep expertise in in vivo methodologies, strong technical skills, and the ability to perform complex operations in a regulated environment.
Capricor Therapeutics
BIOTECHNOLOGY
Cell and exosome-based therapies for rare diseases
LocationSAN DIEGO, CA
Open Jobs32
Rare Diseases
View Company ProfilePipeline
CAP-1002 Allogeneic Cardiosphere-Derived CellsN/A
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of FamiliesN/A
Allogeneic Cardiosphere-Derived CellsPhase 1
CAP-1002 Allogeneic Cardiosphere-Derived CellsPhase 1/2
CenderitidePhase 1/2